Systemic therapies for high-volume metastatic hormone-sensitive prostate cancer: a network meta-analysis

CONCLUSIONS: REZ + ADT were the highest ranked doublet therapy for improvement in OS of patients with high-volume mHSPC, second only to triplet therapy (DAR + DOC + ADT and ABI + DOC + ADT).PMID:37548225 | DOI:10.1080/0284186X.2023.2241985

Source: Acta Oncologica - August 7, 2023 Category: Cancer & Oncology Authors: Zhonghan Zhou Shuai Liu Jingchang Mei Tian Liu Feng Liu Guiming Zhang Source Type: research